Tylenol Maker Kenvue Met With RFK Jr. In A Bid To Keep OTC Painkiller Off Autism List: Report

Published : Sep 12, 2025, 09:20 PM IST
https://stocktwits.com/news-articles/markets/equity/tylenol-kenvue-met-rfk-jr-to-keep-off-autism-list/chw8MshRdDV

Synopsis

According to a Bloomberg report, Kenvue confirmed the meeting with RFK Jr., maintaining that acetaminophen, the active ingredient in Tylenol, does not cause autism.

Tylenol maker Kenvue Inc. (KVUE) reportedly met with the U.S. Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller off a list of treatments causing autism.

According to a Bloomberg report, Kenvue confirmed the meeting with RFK Jr., maintaining that acetaminophen, the active ingredient in Tylenol, does not cause autism.

Get updates to this story developing <directly on Stocktwits<.<

For updates and corrections, email newsroom[at]stocktwits[dot]com.<

PREV

Recommended Stories

CRH, Carvana And Comfort Systems Jump After-Hours As S&P 500 Changes Shake Up Winners And Losers
Northrop Grumman Says Test Data From New Rocket Motor Built In Less Than A Year Looks ‘Promising’